retatrutide clinical trials phase 3 Lilly's triple agonist achieves 16.8% weight loss in trial Retatrutide, an investigational triple hormone
Pay in 4 interest-free payments of $6.86 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5




























